Cambridge Investment Research Advisors’s Innovator US Equity Accelerated 9 Buffer ETF October XBOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-23,097
Closed -$687K 3602
2024
Q3
$687K Sell
23,097
-9,052
-28% -$267K ﹤0.01% 2157
2024
Q2
$941K Sell
32,149
-40,014
-55% -$1.16M ﹤0.01% 1818
2024
Q1
$2.07M Sell
72,163
-42,143
-37% -$1.19M 0.01% 1236
2023
Q4
$3.19M Buy
+114,306
New +$3.07M 0.01% 935
2023
Q3
Sell
-96,697
Closed -$2.49M 3275
2023
Q2
$2.49M Buy
+96,697
New +$2.43M 0.01% 1041

Other funds holding XBOC

Cambridge Investment Research Advisors's XBOC Position: Q4 2024 in Review

Cambridge Investment Research Advisors sold out of Innovator US Equity Accelerated 9 Buffer ETF October (XBOC) in Q4 2024, closing a stake of 23,097 shares — an estimated $687K sold.

Cambridge Investment Research Advisors first reported a position in XBOC in Q2 2023 and held it in 5 quarters. The position peaked at $3.19M in Q4 2023. 41 funds tracked by Wall St. Rank hold XBOC as of Q4 2024.

  • Cambridge Investment Research Advisors reported no remaining Innovator US Equity Accelerated 9 Buffer ETF October position as of Q4 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 23,097 Innovator US Equity Accelerated 9 Buffer ETF October shares in Q4 2024, an estimated $687K.
  • Cambridge Investment Research Advisors first reported a position in Innovator US Equity Accelerated 9 Buffer ETF October in Q2 2023 and held it in 5 quarters.
  • Cambridge Investment Research Advisors's Innovator US Equity Accelerated 9 Buffer ETF October position peaked at $3.19M in Q4 2023.
  • 41 funds tracked by Wall St. Rank held Innovator US Equity Accelerated 9 Buffer ETF October as of Q4 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.